AlphaMaven AlphaMaven

Serena Williams’ Venture Firm Is Building Its Own Grand Slam Portfolio

Reported by Observer
Jul 6, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • Serena Ventures has deployed capital across 100+ portfolio companies with 14 reaching unicorn status, including Indonesian coffee chain Kopi Kenangan and weight-loss app Noom, demonstrating material exit velocity for an early-stage focused fund.
  • • The firm raised $111 million for its first institutional fund in 2022 and maintains a portfolio composition where 54% of companies are founded by women—compared to just 1.1% of total venture funding directed to women in 2025—highlighting a significant market inefficiency that Serena Ventures is capitalizing on.
  • • Portfolio concentration in underrepresented founders reaches 85%, with strategic sector focus on fintech, health tech, and e-commerce, positioning the firm as a specialized allocator in a venture landscape dominated by homogeneous investor networks.
  • • Serena Ventures' investment thesis has matured from stealth founding in 2014 to public-facing institutional operations, with recent examples including a $10 million participation in Teal Health's 2025 funding round alongside established co-investors like Emerson Collective.
Summary
Serena Williams has built Serena Ventures into a consequential early-stage venture capital platform by systematically deploying capital into companies led by women and underrepresented founders—a thesis that has generated measurable returns. Founded quietly in 2014 and brought into public view in 2019, the firm raised $111 million for its first institutional fund in 2022 and has since invested in more than 100 companies across fintech, health tech, and e-commerce verticals. This investment approach addresses a demonstrable market inefficiency: 54% of Serena Ventures' portfolio companies are founded by women, compared to just 1.1% of total venture funding flowing to female founders in 2025, indicating systematic underinvestment in this founder demographic by traditional venture capital.

The fund's track record suggests this strategy generates competitive returns. Fourteen portfolio companies have achieved unicorn status, including Kopi Kenangan, an Indonesian coffee chain, and Noom, a weight-loss application. The broader portfolio composition reveals 85% leadership by underrepresented entrepreneurs, demonstrating consistency in thesis execution across market cycles. Recent investment activity includes a $10 million participation in Teal Health's 2025 funding round, following an initial $8.8 million seed investment in 2023 alongside Metrodora Ventures and Laurene Powell Jobs' Emerson Collective. Teal Health, founded in 2020 by Kara Egan, focuses on expanding access to cervical cancer screening, exemplifying the firm's health tech sector concentration.

Williams has explicitly framed Serena Ventures as a parallel wealth-building strategy to her professional tennis career, describing it in a 2024 TikTok statement as "plan B while I was doing my plan A." Since stepping back from professional competition nearly four years ago, she has intensified focus on venture capital operations while maintaining brand partnerships, including a 2025 collaboration with Ro, a weight-loss telehealth provider. This portfolio approach—combining venture capital allocation, strategic partnerships, and real estate holdings valued above $20 million—represents a diversified wealth management model for institutional investors seeking to understand alternative asset allocation beyond traditional public equities.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Observer Serena Williams’ Venture Firm Is Building Its Own Grand Slam Portfolio